Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMFI Enhancement of ALA-induced PpIX Fluorescence
NCT04221126Phase 4Completed
- Start
- Apr 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of 5-aminolevulinic acid in actinic keratosis (AK), squamous cell carcinoma in situ (SCCIS), basal cell carcinoma (BCC). Started Apr 2019; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)squamous cell carcinoma in situ (SCCIS)basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT04221126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04221126.